A detailed history of Geller Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Geller Advisors LLC holds 14,678 shares of NVO stock, worth $1.22 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
14,678
Previous 12,325 19.09%
Holding current value
$1.22 Million
Previous $1.47 Million 13.97%
% of portfolio
0.08%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$85.0 - $120.04 $200,005 - $282,454
2,353 Added 19.09%
14,678 $1.26 Million
Q3 2024

Nov 15, 2024

BUY
$119.07 - $145.42 $51,795 - $63,257
435 Added 3.66%
12,325 $1.47 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $122 - $146
-1 Reduced 0.01%
11,890 $1.7 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $787,982 - $1.05 Million
7,717 Added 184.88%
11,891 $1.53 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $366,393 - $440,148
4,174 New
4,174 $431,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Geller Advisors LLC Portfolio

Follow Geller Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geller Advisors LLC with notifications on news.